- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Ataxic Cerebral Palsy in Australia
Total 268 results
-
Akesobio Australia Pty LtdCompletedAtopic DermatitisNew Zealand, Australia
-
Neuroscience Trials AustraliaNational Health and Medical Research Council, Australia; Monash UniversityActive, not recruitingAcute Ischemic StrokeAustralia, Finland, New Zealand
-
Amicus TherapeuticsCompleted
-
4D Molecular TherapeuticsActive, not recruiting
-
Amicus TherapeuticsCompletedFabry DiseaseAustralia, Brazil
-
Biomedizinische Forschungs gmbHMedical University of ViennaCompletedToxic Shock Syndrome | Vaccination; SepsisAustria
-
Karl Landsteiner University of Health SciencesParacelsus Medical UniversityCompletedStroke | Dysphagia | Cerebral Infarction | Stroke, AcuteAustria
-
Allon TherapeuticsCompletedProgressive Supranuclear PalsyUnited States, Australia, France, Canada, Germany, United Kingdom
-
BiogenTerminatedSupranuclear Palsy, ProgressiveUnited States, France, Italy, Korea, Republic of, Russian Federation, Spain, United Kingdom, Austria, Canada, Germany, Japan, Australia, Greece
-
PfizerAvailableAtopic DermatitisTaiwan, United States, Australia, Austria, Belgium, Canada, Greece, Mexico, Netherlands, Russian Federation, Spain, Switzerland
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Intracerebral HaemorrhageSpain, Sweden, Singapore, Norway, Italy, Switzerland, Australia, Austria, Belgium, Canada, Denmark, Finland, Germany, Netherlands, United Kingdom
-
AbbVieCompletedA Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic DermatitisDermatitisUnited States, Australia, Canada, Japan, Puerto Rico
-
University College, LondonUniversity of Sydney; University Hospital BirminghamUnknownFabry DiseaseUnited Kingdom, Australia
-
Melbourne HealthSanofiWithdrawnLysosomal Storage Diseases | Fabry Disease | Niemann-Pick Disease, Type C | Gaucher DiseaseAustralia
-
National Cancer Institute (NCI)CompletedRecurrent Childhood Ependymoma | Childhood Infratentorial Ependymoma | Childhood Supratentorial Ependymoma | Recurrent Childhood Cerebellar Astrocytoma | Recurrent Childhood Cerebral Astrocytoma | Recurrent Childhood Subependymal Giant Cell Astrocytoma | Childhood Mixed Glioma | Childhood Oligodendroglioma and other conditionsUnited States, Canada, Australia
-
Neuroscience Trials AustraliaThe Florey Institute of Neuroscience and Mental HealthCompletedIntracerebral HaemorrhageAustralia, Finland, Taiwan, New Zealand, Vietnam
-
AbbVieCompletedAtopic DermatitisUnited States, Australia, Canada, Finland, Germany, Japan, Netherlands, Spain
-
SanofiCompletedAcute Ischemic StrokeKorea, Republic of, Italy, Brazil, Canada, Colombia, Israel, Mexico, Poland, Czech Republic, United States, Australia, Austria, India, South Africa, Turkey
-
Bristol-Myers SquibbCompletedDermatitis, AtopicGermany, Australia, Poland, Canada, Austria, United States, Spain
-
Eli Lilly and CompanyDermira, Inc.CompletedAtopic DermatitisUnited States, Canada, Australia, Poland
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Neurobiological TechnologiesTerminatedStroke | Brain Infarction | Cerebral IschemiaUnited States, Australia, Israel, South Africa, Slovakia, New Zealand, Austria, Czech Republic, Poland, Russian Federation, Switzerland
-
Neurobiological TechnologiesTerminatedStroke | Brain Infarction | Cerebral IschemiaTaiwan, United States, Australia, South Africa, Canada, Czech Republic, Netherlands, Poland, Russian Federation, United Kingdom
-
Medical University of ViennaKarl Landsteiner Institute for Clinical Epilepsy ResearchRecruitingSeizures | Traumatic Brain Injury | Subarachnoid Hemorrhage | Intracerebral Hemorrhage | Cortical Spreading Depolarization and Depression | Ictal-Interictal ContinuumAustria
-
Penumbra Inc.Active, not recruitingCerebral Hemorrhage | Intracerebral Hemorrhage | Brain Hemorrhage | Cerebral Parenchymal HemorrhageUnited States, Germany, Canada, Austria
-
Siolta Therapeutics, Inc.Active, not recruitingAtopic Dermatitis | Type 1 HypersensitivityUnited States, Australia, Puerto Rico
-
SanofiRegeneron PharmaceuticalsCompletedAtopic DermatitisFrance, United States, Australia, Germany, Israel, Italy, Spain, Switzerland, United Arab Emirates, United Kingdom
-
Stryker NeurovascularCompletedIschemic StrokeSpain, Sweden, Germany, Austria
-
University of ZurichSwiss National Science FoundationActive, not recruitingIntraventricular Hemorrhage of PrematuritySwitzerland, Austria
-
Amicus TherapeuticsCompletedFabry DiseaseFrance, Austria, United States, Belgium, Japan, United Kingdom, Denmark, Brazil, Australia, Italy
-
C. R. BardBoston University; Yale UniversityTerminatedIschemic Stroke | Fever | Subarachnoid Hemorrhage | Intracerebral HemorrhageKorea, Republic of, United States, Germany, Switzerland, Austria, Australia
-
Nektar TherapeuticsRecruitingModerate to Severe Atopic DermatitisUnited States, Australia, Canada
-
Klinikum Wels-GrieskirchenGenzyme, a Sanofi CompanyCompletedFocus of Study: Prevalence of Fabry Disease in CKD PopulationAustria
-
Akesobio Australia Pty LtdRecruitingPhase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic DermatitisAtopic DermatitisUnited States, Australia, New Zealand
-
AVROBIOTerminatedFabry DiseaseAustralia, Brazil
-
Novo Nordisk A/SCompletedAcquired Bleeding Disorder | Intracerebral HaemorrhageFinland, Singapore, Australia, Spain, Denmark, Germany, Italy, Taiwan, United Kingdom
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
-
Medical University of ViennaMedical University of GrazUnknownFabry Disease | Left Ventricular HypertrophyAustria
-
AnaptysBio, Inc.RecruitingAtopic Dermatitis EczemaGeorgia, United States, Australia, Canada, Czechia, New Zealand, Poland
-
AllerganCompletedAtopic ConjunctivitisCanada, Czech Republic, United States, Italy, Israel, New Zealand, Spain, India, Germany, Australia, France, United Kingdom
-
MedImmune LLCAmgenCompletedAtopic DermatitisUnited States, Germany, New Zealand, Hungary, Australia, Canada
-
Craig AndersonJohns Hopkins University; Genentech, Inc.; The George Institute for Global Health...RecruitingAcute Ischemic Stroke Patients Receiving Reperfusion TherapyAustralia, United Kingdom, United States, Chile, China, Malaysia, Mexico
-
Hoffmann-La RocheCompletedAtopic DermatitisUnited States, Korea, Republic of, Canada, United Kingdom, Germany, Australia, Poland, Finland, France, Spain, Switzerland, Czechia, Netherlands, Taiwan
-
bluebird bioCompletedCerebral Adrenoleukodystrophy (CALD)United States, Germany, Argentina, Australia, France, United Kingdom
-
LEO PharmaCompletedAtopic DermatitisUnited States, Canada, Australia
-
Amicus TherapeuticsApproved for marketingPhysician Initiated Expanded Access Request for Migalastat in Individual Patients With Fabry DiseaseFabry DiseaseUnited States, Australia
-
LEO PharmaCompletedAtopic DermatitisUnited States, Denmark, United Kingdom, Korea, Republic of, Canada, Italy, Australia, Poland, Russian Federation
-
Botanix PharmaceuticalsCompletedAtopic DermatitisUnited States, Australia, New Zealand
-
Cambridge University Hospitals NHS Foundation TrustUniversity of Pennsylvania; Roche Pharma AG; Genentech, Inc.; Arthritis Research...CompletedMicroscopic Polyangiitis | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Wegener GranulomatosisUnited States, Canada, United Kingdom, Sweden, New Zealand, Ireland, Australia, Italy, Czechia, Japan
-
Dr. Markus Alfred MöhlenbruchMicrovention-Terumo, Inc.; Eppdata HamburgCompletedStroke, Acute | Cerebral Stroke | Cerebrovascular StrokeGermany, Austria, France, Italy, Netherlands